A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
复制标题
DOI：
10.1056/nejmoa1916038
复制
发表时间：
2020-05-28
影响因子：
158.5
通讯作者：
Arslanian, Silva
中科院分区：
文献类型：
--
作者：
Kelly, Aaron S.;Auerbach, Pernille;Arslanian, Silva
背景肥胖是一种慢性疾病，儿科患者的治疗选择有限。利拉鲁肽可能对肥胖青少年的体重控制有用。方法在这项随机双盲试验中，包括56周的治疗期和26周的随访期，我们招募了12-12岁的青少年
Background Obesity is a chronic disease with limited treatment options in pediatric patients. Liraglutide may be useful for weight management in adolescents with obesity.Methods In this randomized, double-blind trial, which consisted of a 56-week treatment period and a 26-week follow-up period, we enrolled adolescents (12 to